aprott/Getty Images
Getty Images; Alyssa Powell/BI
The copycat weight-loss drugs party was supposed to be over, but it's still raging on.
Octavio Jones for BI
Tassii/Getty Images
Sandy Huffaker for The Washington Post via Getty Images

As Novo Nordisk and Eli Lilly struggle to keep up with soaring demand for their popular diabetes and weight loss drugs, healthcare companies are introducing supply trackers to help patients navigate ongoing shortages.


